{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:35:28Z","timestamp":1746322528553},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The diagnosis of Type 2 Diabetes Mellitus (T2DM) is made by demonstrating\nthe hypoglycemic condition, which involves the determination of plasma glucose, and the\nfollow-up of hypoglycemic treatment is performed by assessing the glycated hemoglobin (HbA1c)\nconcentration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The aim of this study was to evaluate the saliva as an alternative sample in assessing the\nadherence to treatment with oral hypoglycemic agents in patients with Type 2 Diabetes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We selected 68 patients with T2DM, who were subjected to venous blood and saliva\ncollection, in addition to answering a standardized questionnaire on adherence to hypoglycemic\ntreatment. Laboratory tests performed on saliva, whole blood, serum or plasma included assessment\nof glycemia, urea, creatinine, uric acid, total cholesterol, HDL-cholesterol, LDL-cholesterol,\nVLDL-cholesterol, and glycated hemoglobin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>It was concluded that 82% of the patients adhered to hypoglycemic treatment based on\nglycated hemoglobin concentration (cut-off value of 7.0%). Comparing the groups that adhered to\nhypoglycemic treatment and those that did not adhere, statistical differences (P&lt;0.05) were observed\nin the glucose, HDL-cholesterol, triglycerides, and insulin use (insulin therapy) parameters.\nPlasma glucose and urea serum concentration showed positive correlations when compared to saliva\nsamples. Regarding the questionnaire, it was found that 35% of the patients presented positive\nscreening for belief barriers and 83% positive score for recall barriers, and the positive screening\ncorrelated with glycated hemoglobin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Data have shown that it is possible to use saliva as an alternative sample to the laboratory\nassessment of hypoglycemic treatment adherence in T2DM patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530323666230110123143","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T06:03:02Z","timestamp":1673416982000},"page":"1068-1076","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of Saliva to Assess the Adherence to Treatment with Oral Hypoglycemic\nAgents in Patients with Type 2 Diabetes"],"prefix":"10.2174","volume":"23","author":[{"given":"Heloisa","family":"de Faria Baltazar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Universidade Federal de S\u00e3o Paulo\/UNIFESP, Diadema, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Luiz Affonso","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Universidade Federal de S\u00e3o Paulo\/UNIFESP, Diadema, Brazil"},{"name":"Clinical Analysis\nLaboratory, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Midori","family":"Castelo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Universidade Federal de S\u00e3o Paulo\/UNIFESP, Diadema, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"da Costa Aguiar Alves","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Universidade Federal de S\u00e3o Paulo\/UNIFESP, Diadema, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00eds","family":"Gasc\u00f3n","sequence":"additional","affiliation":[{"name":"Clinical Analysis\nLaboratory, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaucia Luciano","family":"da Veiga","sequence":"additional","affiliation":[{"name":"Clinical Analysis\nLaboratory, Centro Universit\u00e1rio Sa\u00fade ABC, Santo Andr\u00e9, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edimar Cristiano","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Universidade Federal de S\u00e3o Paulo\/UNIFESP, Diadema, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"Association A.D.","year":"2019","unstructured":"Association A.D.; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142019. Diabetes Care 2019,42(Suppl. 1),S13-S28","journal-title":"Diabetes Care"},{"key":"ref=2","first-page":"58","volume":"39","author":"Kreutzkamp B.","year":"2016","unstructured":"Kreutzkamp B.; Drug treatment of diabetes mellitus type 2. Med Monatsschr Pharm 2016,39(2),58-62","journal-title":"Med Monatsschr Pharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","volume":"134","author":"Bozkurt B.","year":"2016","unstructured":"Bozkurt B.; Aguilar D.; Deswal A.; Dunbar S.B.; Francis G.S.; Horwich T.; Jessup M.; Kosiborod M.; Pritchett A.M.; Ramasubbu K.; Rosendorff C.; Yancy C.; Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the american heart association. Circulation 2016,134(23),e535-e578","journal-title":"Circulation"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1152\/physrev.00034.2018","volume":"99","author":"Saxton S.N.","year":"2019","unstructured":"Saxton S.N.; Clark B.J.; Withers S.B.; Eringa E.C.; Heagerty A.M.; Mechanistic links between obesity, diabetes, and blood pressure: role of perivascular adipose tissue. Physiol Rev 2019,99(4),1701-1763","journal-title":"Physiol Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00508-015-0931-3","volume":"128","author":"Roden M.","year":"2016","unstructured":"Roden M.; Diabetes mellitus: definition, classification and diagnosis. Wien Klin Wochenschr 2016,128(S2),37-40","journal-title":"Wien Klin Wochenschr"},{"key":"ref=6","first-page":"69","volume":"111","author":"Pfeiffer A.F.","year":"2014","unstructured":"Pfeiffer A.F.; Klein H.H.; The treatment of type 2 diabetes. Dtsch Arztebl Int 2014,111(5),69-81","journal-title":"Dtsch Arztebl Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40200-017-0287-5","volume":"16","author":"Naing C.","year":"2017","unstructured":"Naing C.; Mak J.W.; Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: a systematic review. J Diabetes Metab Disord 2017,16(1),2","journal-title":"J Diabetes Metab Disord"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jviromet.2004.09.001","volume":"122","author":"De Cock L.","year":"2004","unstructured":"De Cock L.; Hutse V.; Verhaegen E.; Quoilin S.; Vandenberghe H.; Vranckx R.; Detection of HCV antibodies in oral fluid. J Virol Methods 2004,122(2),179-183","journal-title":"J Virol Methods"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jobcr.2015.08.006","volume":"6","author":"Javaid M.A.","year":"2016","unstructured":"Javaid M.A.; Ahmed A.S.; Durand R.; Tran S.D.; Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res 2016,6(1),67-76","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jcjd.2017.09.005","volume":"41","author":"Simpson S.H.","year":"2017","unstructured":"Simpson S.H.; MacCallum L.; Mansell K.; Pharmacy practice and diabetes care. Can J Diabetes 2017,41(6),549-550","journal-title":"Can J Diabetes"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1590\/S0034-89102012005000013","volume":"46","author":"Ben A.J.","year":"2012","unstructured":"Ben A.J.; Neumann C.R.; Mengue S.S.; The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev Saude Publica 2012,46(2),279-289","journal-title":"Rev Saude Publica"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cca.2007.04.011","volume":"383","author":"Chiappin S.","year":"2007","unstructured":"Chiappin S.; Antonelli G.; Gatti R.; De Palo E.F.; Saliva specimen: A new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007,383(1-2),30-40","journal-title":"Clin Chim Acta"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4239\/wjd.v5.i6.730","volume":"5","author":"Desai G.S.","year":"2014","unstructured":"Desai G.S.; Mathews S.T.; Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J Diabetes 2014,5(6),730-738","journal-title":"World J Diabetes"},{"key":"ref=14","first-page":"140","volume":"39","author":"Mrag M.","year":"2020","unstructured":"Mrag M.; Kassab A.; Omezzine A.; Belkacem C.R.; Ben F.I.F.; Douki N.; Laouani K.C.; Bouslema A.; Ben A.F.; Saliva diagnostic utility in patients with type 2 diabetes: Future standard method. J Med Biochem 2020,39(2),140-148","journal-title":"J Med Biochem"},{"key":"ref=15","first-page":"114","volume":"6","author":"Satish B.N.","year":"2014","unstructured":"Satish B.N.; Srikala P.; Maharudrappa B.; Awanti S.M.; Kumar P.; Hugar D.; Saliva: A tool in assessing glucose levels in diabetes mellitus. J Int Oral Health 2014,6(2),114-117","journal-title":"J Int Oral Health"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4103\/1119-3077.183314","volume":"19","author":"Dhanya M.","year":"2016","unstructured":"Dhanya M.; Hegde S.; Salivary glucose as a diagnostic tool in Type II diabetes mellitus: A case-control study. Niger J Clin Pract 2016,19(4),486-490","journal-title":"Niger J Clin Pract"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223461","volume":"15","author":"Caixeta D.C.","year":"2020","unstructured":"Caixeta D.C.; Aguiar E.M.G.; Cardoso-Sousa L.; Coelho L.M.D.; Oliveira S.W.; Espindola F.S.; Raniero L.; Crosara K.T.B.; Baker M.J.; Siqueira W.L.; Sabino-Silva R.; Salivary molecular spectroscopy: A sustainable, rapid and non-invasive monitoring tool for diabetes mellitus during insulin treatment. PLoS One 2020,15(3)","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1037\/a0040388","volume":"71","author":"Gonzalez J.S.","year":"2016","unstructured":"Gonzalez J.S.; Tanenbaum M.L.; Commissariat P.V.; Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. Am Psychol 2016,71(7),539-551","journal-title":"Am Psychol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/qjmed\/hcm031","volume":"100","author":"Donnelly L.A.","year":"2007","unstructured":"Donnelly L.A.; Morris A.D.; Evans J.M.M.; Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007,100(6),345-350","journal-title":"QJM"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2337\/diacare.25.6.1015","volume":"25","author":"Schectman J.M.","year":"2002","unstructured":"Schectman J.M.; Nadkarni M.M.; Voss J.D.; The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002,25(6),1015-1021","journal-title":"Diabetes Care"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.12.004","volume":"123","author":"Stolar M.","year":"2010","unstructured":"Stolar M.; Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010,123(3),S3-S11","journal-title":"Am J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13104-016-1881-1","volume":"9","author":"Lima-Arag\u00e3o M.V.V.","year":"2016","unstructured":"Lima-Arag\u00e3o M.V.V.; de Oliveira-Junior J.J.; Maciel M.C.G.; Silva L.A.; do Nascimento F.R.F.; Guerra R.N.M.; Salivary profile in diabetic patients: biochemical and immunological evaluation. BMC Res Notes 2016,9(1),103","journal-title":"BMC Res Notes"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.dsx.2019.03.010","volume":"13","author":"Fares S.","year":"2019","unstructured":"Fares S.; Said M.S.M.; Ibrahim W.; Amin T.T.; Saad N.E.S.; Accuracy of salivary glucose assessment in diagnosis of diabetes and prediabestes. Diabetes Metab Syndr 2019,13(2),1543-1547","journal-title":"Diabetes Metab Syndr"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/2380084420954354","volume":"6","author":"Khoury Z.H.","year":"2021","unstructured":"Khoury Z.H.; Illesca P.; Sultan A.S.; Salivary fructosamine as a noninvasive glycemic biomarker: a systematic review. JDR Clin Trans Res 2021,6(4),382-389","journal-title":"JDR Clin Trans Res"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666230110123143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212514\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530323666230110123143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T14:19:09Z","timestamp":1691417949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212514\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530323666230110123143","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}